Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Flexi Cap Fund median (49 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | BANDHAN Flexi Cap Fund |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹93.24 |
| 12 Apr 2015 | ₹155.89 |
| 31 May 2016 | ₹116.40 |
| 19 Jul 2017 | ₹134.19 |
| 07 Sep 2018 | ₹139.81 |
| 27 Oct 2019 | ₹127.97 |
| 15 Dec 2020 | ₹131.59 |
| 03 Feb 2022 | ₹169.44 |
| 25 Mar 2023 | ₹149.39 |
| 12 May 2024 | ₹187.77 |
| 01 Jul 2025 | ₹205.14 |
| 20 Aug 2026 | ₹195.08 |
| Metric | Bandhan · Direct · IDCW NAV ₹52.21 Very High risk ★☆☆☆☆ | Category median Flexi Cap Fund · 49 funds |
|---|---|---|
| -4.87% | +2.34% | |
| +5.62% | +12.85% | |
| +4.82% | +10.36% | |
| +4.56% | +8.08% | |
| +5.03% | +11.66% | |
| +3.14% | — | |
| +5.89% | +12.67% | |
| +5.53% | +11.75% | |
| +5.59% | +9.39% | |
| Risk | ||
| 14.24% | 14.56% | |
| -0.06 | 0.38 | |
| -0.08 | 0.50 | |
| -48.49% | -33.86% | |
| Nifty 500 | — | |
| -5.68% | +0.65% | |
| 0.92 | 0.98 | |
| 75.9% | 100.2% | |
| 101.1% | 97.9% | |
| 1.52% | 0.86% | |
| ₹7,269Cr | ₹4,009Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹1.00K | — | |
| 14% | 37% | |
| Gaurav Satra | — | |
| 02 Jan 2013 | — | |
| 81 | — | |
| 43.8% | — | |
| 2.4% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.